FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W182142912> ?p ?o ?g. }

• W182142912 endingPage "487" @default.
• W182142912 startingPage "479" @default.
• W182142912 abstract "Objectives The purpose of this study was to determine the incidence and demographic characteristics of patients experiencing cardiac rupture after thrombolytic and adjunctive anticoagulant therapy and to identify possible associations between the mechanism of thrombin inhibition (indirect, direct) and the intensity of systemic anticoagulation with its occurrence. Background Cardiac rupture is responsible for nearly 15% of all in-hospital deaths among patients with myocardial infarction (MI) given thrombolytic agents. Little is known about specific patient- and treatment-related risk factors. Methods Patients (n = 3,759) with MI participating in the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9A and B trials received intravenous thrombolytic therapy, aspirin and either heparin (5,000 U bolus, 1,000 to 1,300 U/h infusion) or hirudin (0.1 to 0.6 mg/kg bolus, 0.1 to 0.2 mg/kg/h infusion) for at least 96 h. A diagnosis of cardiac rupture was made clinically in patients with sudden electromechanical dissociation in the absence of preceding congestive heart failure, slowly progressive hemodynamic compromise or malignant ventricular arrhythmias. Results A total of 65 rupture events (1.7%) were reported—all were fatal, and a majority occurred within 48 h of treatment. Patients with cardiac rupture were older, of lower body weight and stature and more likely to be female than those without rupture (all p < 0.001). By multivariable analysis, age >70 years (odds ratio [OR] 3.77; 95% confidence interval [CI] 2.06, 6.91), female gender (OR 2.87; 95% CI 1.44, 5.73) and prior angina (OR 1.82; 95% CI 1.05, 3.16) were independently associated with cardiac rupture. Independent predictors of nonrupture death included age >70 years (OR 3.68; 95% CI 2.53, 5.35) and prior MI (OR 2.14; 95%, CI 1.45, 3.17). There was no association between the type of thrombin inhibition, the intensity of anticoagulation and cardiac rapture. Conclusions Cardiac rupture following thrombolytic therapy tends to occur in older patients and may explain the disproportionately high mortality rate among women in prior clinical trials. Unlike major hemorrhagic complications, there is no evidence that the intensity of anticoagulation associated with heparin or hirudin administration influences the occurrence of rupture." @default.
• W182142912 created "2016-06-24" @default.
• W182142912 creator A5004956623 @default.
• W182142912 creator A5019612250 @default.
• W182142912 creator A5026602252 @default.
• W182142912 creator A5074424207 @default.
• W182142912 creator A5080397161 @default.
• W182142912 creator A5088024345 @default.
• W182142912 creator A5089213415 @default.
• W182142912 date "1999-02-01" @default.
• W182142912 modified "2023-10-12" @default.
• W182142912 title "Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists" @default.
• W182142912 cites W140949216 @default.
• W182142912 cites W1483203217 @default.
• W182142912 cites W1499049782 @default.
• W182142912 cites W1533600198 @default.
• W182142912 cites W183560997 @default.
• W182142912 cites W1969768219 @default.
• W182142912 cites W1977452105 @default.
• W182142912 cites W1977846703 @default.
• W182142912 cites W1980136758 @default.
• W182142912 cites W1980335897 @default.
• W182142912 cites W1980883485 @default.
• W182142912 cites W1990049543 @default.
• W182142912 cites W1990382263 @default.
• W182142912 cites W1999170383 @default.
• W182142912 cites W2000117558 @default.
• W182142912 cites W2010280774 @default.
• W182142912 cites W2019407457 @default.
• W182142912 cites W2024959470 @default.
• W182142912 cites W2025974255 @default.
• W182142912 cites W2026458636 @default.
• W182142912 cites W2040016604 @default.
• W182142912 cites W2044313563 @default.
• W182142912 cites W2061429289 @default.
• W182142912 cites W2062729330 @default.
• W182142912 cites W2064475520 @default.
• W182142912 cites W2072995276 @default.
• W182142912 cites W2075404469 @default.
• W182142912 cites W2078686553 @default.
• W182142912 cites W2085422645 @default.
• W182142912 cites W2092988653 @default.
• W182142912 cites W2093039963 @default.
• W182142912 cites W2118895431 @default.
• W182142912 cites W2152190517 @default.
• W182142912 cites W2312388685 @default.
• W182142912 cites W2313702971 @default.
• W182142912 cites W2323549932 @default.
• W182142912 cites W2326354230 @default.
• W182142912 cites W2340149484 @default.
• W182142912 cites W2341117414 @default.
• W182142912 cites W3025057188 @default.
• W182142912 cites W3170680033 @default.
• W182142912 cites W4237343754 @default.
• W182142912 cites W802046826 @default.
• W182142912 doi "https://doi.org/10.1016/s0735-1097(98)00582-8" @default.
• W182142912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9973029" @default.
• W182142912 hasPublicationYear "1999" @default.
• W182142912 type Work @default.
• W182142912 sameAs 182142912 @default.
• W182142912 citedByCount "136" @default.
• W182142912 countsByYear W1821429122012 @default.
• W182142912 countsByYear W1821429122013 @default.
• W182142912 countsByYear W1821429122014 @default.
• W182142912 countsByYear W1821429122015 @default.
• W182142912 countsByYear W1821429122016 @default.
• W182142912 countsByYear W1821429122017 @default.
• W182142912 countsByYear W1821429122018 @default.
• W182142912 countsByYear W1821429122019 @default.
• W182142912 countsByYear W1821429122020 @default.
• W182142912 countsByYear W1821429122021 @default.
• W182142912 countsByYear W1821429122022 @default.
• W182142912 countsByYear W1821429122023 @default.
• W182142912 crossrefType "journal-article" @default.
• W182142912 hasAuthorship W182142912A5004956623 @default.
• W182142912 hasAuthorship W182142912A5019612250 @default.
• W182142912 hasAuthorship W182142912A5026602252 @default.
• W182142912 hasAuthorship W182142912A5074424207 @default.
• W182142912 hasAuthorship W182142912A5080397161 @default.
• W182142912 hasAuthorship W182142912A5088024345 @default.
• W182142912 hasAuthorship W182142912A5089213415 @default.
• W182142912 hasConcept C126322002 @default.
• W182142912 hasConcept C156957248 @default.
• W182142912 hasConcept C164705383 @default.
• W182142912 hasConcept C2777628954 @default.
• W182142912 hasConcept C2778198053 @default.
• W182142912 hasConcept C2779581417 @default.
• W182142912 hasConcept C2910755090 @default.
• W182142912 hasConcept C42219234 @default.
• W182142912 hasConcept C43376680 @default.
• W182142912 hasConcept C500558357 @default.
• W182142912 hasConcept C71924100 @default.
• W182142912 hasConceptScore W182142912C126322002 @default.
• W182142912 hasConceptScore W182142912C156957248 @default.
• W182142912 hasConceptScore W182142912C164705383 @default.
• W182142912 hasConceptScore W182142912C2777628954 @default.
• W182142912 hasConceptScore W182142912C2778198053 @default.
• W182142912 hasConceptScore W182142912C2779581417 @default.

• next